Filter
1805
Filtered Results: 1805
Text search:
National
Department
of
Health
(Republic
of
South
Africa)
Featured
Recommendations
146
New Publications
472
Language
Document type
No document type
1034
Studies & Reports
395
Guidelines
187
Manuals
76
Strategic & Response Plan
72
Training Material
17
Situation Updates
10
Fact sheets
9
Resource Platforms
2
Infographics
2
App
1
Countries / Regions
South Africa
120
Global
109
Nigeria
52
Kenya
48
Uganda
48
Africa
47
Liberia
44
Ethiopia
42
Zambia
36
Congo, Democratic Republic of
34
Tanzania
33
Sierra Leone
30
Malawi
30
Rwanda
28
Ghana
26
Latin America and the Carribbean
23
South Sudan
23
Namibia
21
Asia
17
Western and Central Europe
17
East and Southern Africa
16
Myanmar / Burma
16
Mozambique
15
Guinea
14
Bangladesh
14
India
14
West and Central Africa
13
Lesotho
11
Syria
11
Zimbabwe
11
Botswana
11
Cameroon
10
Yemen
10
South–East Asia Region
9
Central African Republic
9
Colombia
8
Senegal
8
Philippines
8
Sudan
8
Haiti
7
Middle East and North Africa
7
Indonesia
7
Ukraine
6
Afghanistan
6
Venezuela
6
Pakistan
6
Benin
5
Germany
4
Brazil
4
Mali
4
Angola
4
Somalia
4
Eswatini/ Swaziland
4
Nepal
3
Gambia
3
Albania
3
Cambodia
3
Jordan
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Lebanon
3
Iraq
3
Ecuador
3
Togo
2
China
2
Chile
2
Burkina Faso
2
Burundi
2
Peru
2
North America
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Russia
2
Palestine
2
Chad
2
Tajikistan
1
Timor Leste/ East Timor
1
Thailand
1
Mexico
1
Turkey
1
Iran
1
Niger
1
Morocco
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Turkmenistan
1
Japan
1
France
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Bolivia
1
Eastern Europe
1
Papua New Guinea
1
Sri Lanka
1
Djibouti
1
Egypt
1
Greece
1
Georgia
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
598
Clinical Guidelines
148
Public Health
126
Women & Child Health
113
Key Resources
108
Capacity Building
28
Pharmacy & Technologies
15
Toolboxes
HIV
186
Mental Health
163
COVID-19
100
TB
99
Disability
83
NTDs
72
Planetary Health
71
Rapid Response
67
Ebola & Marburg
54
Global Health Education
49
Conflict
45
Refugee
41
Caregiver
39
Health Financing Toolbox
36
AMR
36
NCDs
28
Pharmacy
27
Natural Hazards
19
Cholera
12
Zika
9
Polio
9
Specific Hazards
7
Social Ethics
3
Malaria
2
South Sudan
1
Typhoon
1
This World Health Organization (WHO) and the International Labour Organization (ILO) joint guidelines production aims at harnessing the contribution of employers and workers towards the control of TB. It covers all the practical steps involved in establishing TB control activities, including (for la...
WHO guideline on preventing early pregnancy and poor reproductive outcomes among adolescents in low- and middle-income countries
recommended
New
The objectives of this guideline are the same as those of the 2011 edition, namely to provide evidence-based normative guidance on interventions to improve adolescent morbidity and mortality by reducing the chances of early pregnancy and its resulting poor health outcomes. The specific objectives of...
Cholera is a major health risk in many parts of the world, affecting millions of people every year. Since mid-2021, the world has been facing an acute upsurge of the 7th cholera pandemic, which is characterized by the number, size and concurrence of multiple outbreaks, the spread to areas that had b...
The global burden of disease associated with air pollution exposure exacts a massive toll on human health worldwide: exposure to air pollution is estimated to cause millions of deaths and lost years of healthy life annually. The burden of disease attributable to air pollution is now estimated to be ...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that derive from it, is still a work in progress.This document has two main purposes:
• to provide an up...
Pneumonia kills more children than any other illness – more than AIDS, malaria and measles combined. Over 2 million children die from pneumonia each year, accounting for almost 1 in 5 under five deaths worldwide. Yet, little attention is paid to this disease. This joint UNICEF/WHO report examines ...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
The 2023 Country Presence Report provides an overview of what WHO does in countries to advance towards the SDGs and implement GPW13, how we do it, with whom we work, and what is needed to overcome challenges for achieving results and impact in countries.
The document contains preliminary report on all aspects of WHO’s response in the Ebola outbreak. WHO Member States will discuss the report at the sixty-eighth World Health Assembly.
WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively. ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental health treatments and progression towards universal health coverage.
This manual provides managers and others responsible for plan...
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
Trachoma is the world’s leading infectious cause of blindness. It is one of 18 neglected
tropical diseases (NTDs) that affect over one billion of the world’s poorest people.
The plan contains the latest available evidence on the extent of insecticide resistance around the world, and puts forward a strategy for global and country levels, identifying clear roles and timelines for all stakeholders. The GPIRM also summarizes information about innovative new products being d...
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
